Alberto Tesconi Croci

Alberto Tesconi Croci

Auto-generated profile, based on publicly available information

Alberto Tesconi Croci

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Clinics
Verified
Journal Article
Open access
PDF file
HCHenrique Berwanger Cabrita
Henrique Berwanger Cabrita
ACAlberto Tesconi Croci
Alberto Tesconi Croci
OCOlavo Pires de Camargo
Olavo Pires de Camargo
ALAna Lúcia Lei Munhoz de Lima
Ana Lúcia Lei Munhoz de Lima
PURPOSE: Our purpose was to compare 2 methods of treatment of chronic infection in hip arthroplasties-with or without an antibiotic-loaded cement spacer. METHODS: In a prospective study, we treated 68 infected hip arthroplasties with discharging sinuses and bone loss, comparing 30 patients treated in 2 stages without the use of a spacer (control group) and 38 patients treated with a vancomycin-loaded spacer (study group). The average follow-up was 4 years (2-8.5 years). One patient died of unrelated causes 4 months after first-stage surgery and was excluded from the study. RESULTS: The 2-stage surgery without spacer controlled the infection in 66.7% of patients, and the 2-stage surgery using the spacer controlled it in 89.1% (P < 0.05). At last follow-up, the average Harris Hip Score increased from 19.3 to 69.0 in the control group versus 19.7 to 75.2 in the study group (P > 0.05). The average leg length discrepancy was 2.6 cm in the control group and 1.5 cm in the study group (P < 0.05). The patients treated with a spacer had better clinical results (81.5% of patients with good results against 60.0% for the control group). CONCLUSION: The use of an antibiotic-loaded spacer in the 2-stage treatment of infected hip arthroplasties provides better infection control with good functional results and is superior to treatment in 2 stages without a spacer. Level of Evidence: Therapeutic study, Level I-1.

1 January 2014 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
HGHenrique M.C. Gurgel
Henrique M.C. Gurgel
ACAlberto T. Croci
Alberto T. Croci
HCHenrique A.B.A. Cabrita
Henrique A.B.A. Cabrita
JVJosé Ricardo N. Vicente
José Ricardo N. Vicente
MLMarcos C. Leonhardt
Marcos C. Leonhardt
JRJoão Carlos Rodrigues
João Carlos Rodrigues

1 April 2005 in Clinics
Verified
Journal Article
Open access
PDF file
MEMauricio Etchebehere
Mauricio Etchebehere
OCOlavo Pires de Camargo
Olavo Pires de Camargo
ACAlberto Tesconi Croci
Alberto Tesconi Croci
COClaudia Regina C. M. Oliveira
Claudia Regina C. M. Oliveira
ABAndré Mathias Baptista
André Mathias Baptista
To evaluate the oncological outcome of patients with grade I chondrosarcomas according to the type of surgical treatment performed, since there is still controversy regarding the need for aggressive resections to reach a successful outcome. The records of 23 patients with grade I chondrosarcomas were reviewed. The mean age was 38.4 years, ranging from 11 to 70 years; 52% were men and 48% were women. The femur was the site of 13 tumors. The tumors were staged as IA (17, 74%) and IB (6, 26%). Regarding tumor location, 74% (17) were medullary, 22% (5) were peripheral, and 4% (1) was indeterminate. Tumor size ranged from 2 to 25 cm, mean 7.9 cm. Regarding the surgical procedure, 11 patients underwent intralesional resection, 9 patients underwent wide resection, and 3 underwent radical resection. The follow-up period ranged from 24 to 192 months. None of the patients developed local recurrence or metastases; 7 patients had other general complications. This data supports the use of less aggressive procedures for treatment of low-grade chondrosarcomas.

1 April 2002 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
OCOlavo Pires De Camargo
Olavo Pires De Camargo
TMTelma Murias Dos Santos Machado
Telma Murias Dos Santos Machado
ACAlberto Tesconi Croci
Alberto Tesconi Croci
COCláudia Regina G C M De Oliveira
Cláudia Regina G C M De Oliveira
MGMarcelo Abrantes Giannotti
Marcelo Abrantes Giannotti
LMLucy Akemi Matsumoto
Lucy Akemi Matsumoto
The authors present their experience in the treatment of 24 patients with primary bone lymphoma. Eighty-one patients treated between 1955 and 1999 were evaluated, and 57 were excluded because of misdiagnosis. The male to female ratio was 7:5 and the median age was 38.5 years (range, 18–69 years). Two patients had human immunodeficiency virus. Seventeen patients had intermediate-grade lymphomas (Working Formulation), nine patients had centroblastic subtype (Kiel), and 22 patients had B immunophenotype. Nine patients had combined treatment with chemotherapy and radiation therapy, and nine patients had chemotherapy alone. The mean followup was 13.2 years (range, 1.5–37.3 years). Three patients had surgery, two because of subtrochanteric fractures (one patient had closed reduction and internal fixation and the other patient had resection and endoprosthesis reconstruction). The third patient presented with myelocompression at the thoracic level, and he had decompression surgery. Only one patient had radiation therapy and two patients had no treatment. There have been no local recurrences in 17 patients (70.8%). Seven patients (29.2%) died with evidence of disease within a followup of 11 months. The results of the current study showed that patients with primary bone lymphoma have a good prognosis when they are treated with chemotherapy, regardless of whether radiation therapy was given. Surgery usually is appropriate for patients with fractures.

1 January 2012 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
PDF file
ASAdriana Lucia Pastore e Silva
Adriana Lucia Pastore e Silva
MDMarco Kawamura Demange
Marco Kawamura Demange
RGRiccardo Gomes Gobbi
Riccardo Gomes Gobbi
TSTânia Fernanda Cardoso da Silva
Tânia Fernanda Cardoso da Silva
JPJosé Ricardo Pécora
José Ricardo Pécora
ACAlberto Tesconi Croci
Alberto Tesconi Croci
OBJETIVO: Traduzir, adaptar culturalmente e validar o "Knee Society Score" (KSS) para a língua portuguesa e verificar suas propriedades de medida, reprodutibilidade e validade. MÉTODO: Avaliados 70 pacientes de ambos os sexos, em estudo clínico transversal, idade entre 55 e 85 anos, osteoartrose primária submetidos a artroplastia total de joelho, com o questionário KSS pelo avaliador 1 (inglês) e após 30 minutos pelo avaliador 2 (português) no pré- operatório e após três e seis meses de pós-operatório. RESULTADOS: O índice alfa de Cronbach e a diagramação de Bland-Altman não detectaram diferença entre as médias das duas avaliações no pré-operatório (p=1,000), com três meses (p=0,991) e seis meses de pós-operatório (p=0,985) na pontuação do joelho e na nota da função do joelho, p=1,000 nos três períodos. CONCLUSÃO: A versão brasileira do Knee Society Score, o Escore da Sociedade do Joelho, mostrou ser um instrumento de fácil compreensão e aplicação; válido e confiável para medir a pontuação e função do joelho de pacientes brasileiros submetidos a ATJ. Nível de Evidências: Estudos diagnósticos - Nivel de Evidência I, Teste de critérios diagnósticos desenvolvidos anteriormente em pacientes consecutivos (com padrão de referência "ouro" aplicado).

1 June 2008 in Clinics
Verified
Journal Article
Open access
PDF file
JVJose Ricardo Negreiros Vicente
Jose Ricardo Negreiros Vicente
ACAlberto Tesconi Croci
Alberto Tesconi Croci
OCOlavo Pires de Camargo
Olavo Pires de Camargo
Our primary aim was to evaluate whether there is really less bleeding in patients for whom the minimally invasive posterior approach is used in comparison with the direct lateral approach for primary total hip arthroplasty. Our secondary aim was to evaluate the clinical functional results after six months as well as the postoperative radiographic result. In a comparative non-random prospective study, 76 adult patients underwent elective total hip arthroplasty using one of two approaches. The minimally invasive posterior approach (34 cases; mini-incision group) was compared with the standard direct lateral approach (42 cases; control group). Lower total estimated bleeding (means of 1083.5 ml versus 1682.3 ml; p < 0.001) and lower intraoperative bleeding (means of 745.6 ml versus 1282.8 ml; p < 0.001) were found in the mini-incision group. There was, however, no difference in the volume of blood drained after the operation (means of 340 ml and 399 ml; p = 0.77). There was also a difference between the two groups regarding the need for allogenic transfusion (8.8% in the mini-incision group versus 28.6%, p = 0.02). We observed a better clinical result in the mini-incision group (p = 0.002) despite the lack of difference between the two groups in relation to the radiographic result. Our results draw attention to the possibility that other authors may have underestimated blood losses when using minimally invasive approaches. The minimally invasive approach gave rise to a positive final impression with regard to lower blood loss.